Why Oncology and Cardiology Are Key Applications in the Radiopharmaceutical Theranostics Market
The global radiopharmaceutical theranostics market is growing as healthcare providers invest in targeted diagnostic and therapeutic solutions for cancer and cardiovascular diseases. The market was valued at USD 2.11 billion in 2024 and is projected to reach USD 4.374 billion by 2035, growing at a CAGR of 6.85%. The Radiopharmaceutical Theranostics Market includes oncology, cardiology,...
0 Comments 0 Shares 70 Views 0 Reviews